RachaelGraceMD

Associate Professor, Boston Children's Hospital

Dr. Grace is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
300 Longwood Ave
Childrens Hospital Boston Karp 8
Boston, MA 02115
Phone+1 617-355-6000

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2007 - 2010
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2003 - 2006
The Warren Alpert Medical School of Brown UniversityClass of 2003

PubMed

Abstracts/Posters

Comorbidities and Complications in Adults with Pyruvate Kinase Deficiency
Rachael F. Grace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children
Rachael F. Grace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
The Effect of Pathway to Diagnosis for Childhood ITP on Caregiver Quality of Life at Time of Diagnosis
Rachael F. Grace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Development of Patient-Reported Outcome Measures (Symptoms and Impacts) in Adults with Pyruvate Kinase Deficiency
Rachael F. Grace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Characterization of the Severe Phenotype of Pyruvate Kinase Deficiency
Rachael F. Grace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Pyruvate Kinase (PK) Protein and Enzyme Levels in the Diagnosis and Clinical Phenotype of PK Deficiency
Rachael F. Grace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Join now to see all

Lectures

Special Education Session on ASH Clinical Practice Guidelines on Immune Thrombocytopenia
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
An Ongoing Global, Longitudinal, Observational Study of Patients with Pyruvate Kinase Deficiency: The PEAK Registry
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Expression Differences Distinguish Pediatric Acute and Chronic ITP Using RNA Sequencing
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Join now to see all

Mitapivat Produces Durable Hemoglobin Responses in Patients with Pyruvate Kinase DeficiencyDecember 11th, 2021
More Than 110 Dana-Farber Affiliated Faculty Named as 2021 Top Doctors in Boston MagazineJanuary 5th, 2021
Mitapivat Elicits Positive Response in Pyruvate Kinase DeficiencySeptember 4th, 2019
Join now to see all